Back
Avadel Pharmaceuticals PLC 10K Form
Sell
47
AVDL
Avadel Pharmaceuticals PLC
Last Price:
$9.01
Seasonality Move:
5.62%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-11-08 | 10Q | AVDL/Avadel Pharmaceuticals PLC Quarterly |
| 2023-08-09 | 10Q | AVDL/Avadel Pharmaceuticals PLC Quarterly |
| 2023-05-04 | 10Q | AVDL/Avadel Pharmaceuticals PLC Quarterly |
| 2022-11-09 | 10Q | AVDL/Avadel Pharmaceuticals PLC Quarterly |
| 2022-08-09 | 10Q | AVDL/Avadel Pharmaceuticals PLC Quarterly |
| 2022-05-09 | 10Q | AVDL/Avadel Pharmaceuticals PLC Quarterly |
Receive AVDL News And Ratings
See the #1 stock for the next 7 days that we like better than AVDL
AVDL Financial Statistics
Sales & Book Value
| Annual Sales: | $169.1M |
|---|---|
| Cash Flow: | $-8.2M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.77 |
| Price / Book: | 11.77 |
Profitability
| EPS (TTM): | -0.27000 |
|---|---|
| Net Income (TTM): | $-26.4M |
| Gross Margin: | $153.8M |
| Return on Equity: | -35.57% |
| Return on Assets: | -16.19% |
Avadel Pharmaceuticals PLC Earnings Forecast
Key Avadel Pharmaceuticals PLC Financial Ratios
-
The Gross Profit Margin over the past 29 years for AVDL is 90.97%.
-
The Selling, General & Administrative Expenses for AVDL have been equal to 107.05% of Gross Profit Margin.
-
The Research & Development expenses have been 8.99% of Revenue.
-
The Net Earning history of AVDL is -28.87% of Total Revenues.
-
Per Share Earnings over the last 29 years have been positive in 16 years.
Avadel Pharmaceuticals PLC Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | AVDL |
| CUSIP: | 05337M |
| Website: | avadel.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 2.73 |
| Quick Ratio: | 2.12 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 12.24 |
AVDL Technical Analysis vs Fundamental Analysis
Sell
47
Avadel Pharmaceuticals PLC (AVDL)
is a Sell
Is Avadel Pharmaceuticals PLC a Buy or a Sell?
-
Avadel Pharmaceuticals PLC stock is rated a SellThe current Avadel Pharmaceuticals PLC [AVDL] share price is $9.01. The Score for AVDL is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.